Anemia in young patients with ischaemic stroke
L Kellert, M Kloss, A Pezzini, TM Metso, AJ Metso, S Debette, D Leys, V Caso, V Thijs, A Bersano, E Touze, T Tatlisumak, H Gensicke, PA Lyrer, J Boesel, ST Engelter, C Grond-Ginsbach
European Journal of Neurology | WILEY | Published : 2015
BACKGROUND AND PURPOSE: To investigate the association of anemia on admission with ischaemic stroke (IS), stroke severity and early functional outcome in patients with cervical artery dissection (CeAD) or with IS of other causes (non-CeAD-IS patients). METHODS: The study sample comprised all patients from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) study without pre-existing disability and with documentation of stroke severity and hemoglobin (Hb) concentration on admission. Anemia was classified as mild (Hb < 12 g/dl in women and Hb < 13 g/dl in men) or moderate to severe (Hb < 10 g/dl in women and Hb < 11 g/dl in men). Stroke severity on admission was assessed with..View full abstract
Awarded by Swiss National Science Foundation
The authors thank the patients who participated in this study and all staff and participants at all CADISP centers for their contributions. The CADISP study has received funding from the Contrat de Projet Etat - Region 2007, Centre National de Genotypage, Emil Aaltonen Foundation, Paavo Ilmari Ahvenainen Foundation, Helsinki University Central Hospital Research Fund, Academy of Finland, Helsinki University Medical Foundation, Paivikki and Sakari Sohlberg Foundation, Aarne Koskelo Foundation, Maire Taponen Foundation, Aarne and Aili Turunen Foundation, Lilly Foundation, Alfred Kordelin Foundation, Finnish Medical Foundation, Orion Farmos Research Foundation, Maud Kuistila Foundation, the Finnish Brain Foundation, Biomedicum Helsinki Foundation, Projet Hospitalier de Recherche Clinique Regional, Fondation de France, Genopole de Lille, Adrinord, EA2691, Institut Pasteur de Lille, INSERM U744, Basel Stroke-Funds, Kathe-Zingg-Schwichtenberg-Fonds of the Swiss Academy of Medical Sciences, the Swiss National Science Foundation (33CM30-124119; 33CM30-140340/1) and the Swiss Heart Foundation.